Endometrial Cancer Trial, Recruiting (NCT06538337)

Endometrial Cancer Trial, Recruiting NCT06538337 Sponsor: Jonsson Comprehensive Cancer Center Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06538337 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with endometrial (uterine) or cervical cancer, confirmed by a laboratory test on a tissue sample
You have had surgery to remove the main tumor
Your cancer is at a stage where the standard recommended treatment after surgery is radiation therapy to the pelvic area only (without chemotherapy) — this applies to certain stages of endometrial or cervical cancer (confirm with trial site)
You are 18 years of age or older
You are generally well enough to carry out daily activities, even if some tasks are limited — your doctor will assess this using a standard health scale

Who may not be able to join:

You would normally be recommended to receive chemotherapy alongside radiation therapy as part of your standard care
You are currently receiving treatment for a different type of cancer
You have previously had radiation therapy to the same area of the body that would need to be treated in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Puja S. Venkat, MD, University of California at Los Angeles

Phone: 310-794-2971

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06538337

Sponsor: Jonsson Comprehensive Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 310-794-2971

More information: https://clinicaltrials.gov/study/NCT06538337

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with endometrial (uterine) or cervical cancer, confirmed by a laboratory test on a tissue sample
You have had surgery to remove the main tumor
Your cancer is at a stage where the standard recommended treatment after surgery is radiation therapy to the pelvic area only (without chemotherapy) — this applies to certain stages of endometrial or cervical cancer (confirm with trial site)
You are 18 years of age or older
You are generally well enough to carry out daily activities, even if some tasks are limited — your doctor will assess this using a standard health scale

Who may not be able to join:

You would normally be recommended to receive chemotherapy alongside radiation therapy as part of your standard care
You are currently receiving treatment for a different type of cancer
You have previously had radiation therapy to the same area of the body that would need to be treated in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jonsson Comprehensive Cancer Center

Registry

ClinicalTrials.gov

Start date

24 July 2024

Est. completion

26 July 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluate acute radiation toxicity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov